Artivion | CRY - 销售毛利



金融业
股票价格
USD
资产
USD 1.07B
现金及等价物
USD 77.32M
销售成本
USD 42.85M
流动资产
USD 371.38M
流动负债
USD 106.93M
债务
USD 317.78M
EBIT
USD 4.79M
EBITDA
USD 22.72M
员工
1.5K
EPS每股收益
USD -0.02
股本和储备
USD 445.59M
销售毛利
USD 73.14M
债务利息支出
USD 5.53M
利息收入
USD -0.05
贷款资金
USD 363.42M
市值
USD 986.1M
净收入
USD 2.42M
营业费用
USD 111.2M
营业利润
USD 4.79M
普通股股本
USD 47.84M
PE价格收益
212.38
税前利润
USD 11.4M
销售收入
USD 115.99M
销售和管理费用
USD 55.75M
股票
USD 103.36M
贸易债权人
USD 20.87M
应收帐款人
USD 103.68M


销售毛利 更改 日
Abbott USD 6.65B 787M 2026-06
Accuray USD 41.89M 7.42M 2024-12
AngioDynamics USD 44.78M 2.93M 2025-09
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 109.31M 3.97M 2026-03
Baxter International USD 1.14B 251M 2026-06
Becton, Dickinson and Co. USD 2.32B 161M 2026-06
Boston Scientific USD 3.82B 210M 2026-06
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Inogen USD 41.34M 1.39M 2024-09
Integra LifeSciences USD 215.97M 2.77M 2026-06
J&J USD 18.55B 1.31B 2026-06
Mesa Laboratories USD 39.75M 4.3M 2024-12
Orthofix International USD 153.28M 4.76M 2025-12
Pfizer USD -248M 11.29B 2026-06
ResMed USD 861.22M 29.76M 2026-06
Stryker USD 4.5B 688M 2026-06
Tandem Diabetes Care USD 144.78M 7.99M 2026-06
Teleflex USD 331.71M 24.28M 2026-06
Terumo JPY 178.54B 29.52B 2026-06
Trinity Biotech USD 6.47M 1.59M 2025-09